Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT1091220367Recruiting
Trial of remifentanil and fentanyl (2 arms), sponsored by Shunji Kobayashi, M.D., PhD. Primary endpoint: Percent decrease from baseline of SBP, DBP, MBP, and HR. Started Jul 2018; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT1091220367.